ConductScience.org, home

Paper · 39200178

Using microRNAs Networks to Understand Pancreatic Cancer-A Literature Review.

Przybyszewski O and 5 others. Biomedicines, 2024. Cited by 6 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Using microRNAs Networks to Understand Pancreatic Cancer-A Literature Review. Papers, record 39200178. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39200178

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Using microRNAs Networks to Understand Pancreatic Cancer-A Literature Review.
PubMed
Journal
Biomedicines
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.92, provisional
iCite
Revised in PubMed
2024-09-01
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Przybyszewski OOskarhttps://orcid.org/0000-0002-0037-5991
2Mik MMichałhttps://orcid.org/0000-0001-6290-1806
3Nowicki MMichał
4Kusiński MMichałhttps://orcid.org/0000-0003-2145-0708
5Mikołajczyk-Solińska MMelaniahttps://orcid.org/0000-0002-2913-098X
6Śliwińska AAgnieszkahttps://orcid.org/0000-0002-6864-0704

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References189

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117,634,527WNT signaling pathway and stem cell signaling network.Clin Cancer Res2007https://conductscience.org/library/papers/17634527PubMed
215,806,104Combinatorial microRNA target predictions.Nat Genet2005https://conductscience.org/library/papers/15806104PubMed
323,359,184Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL-2 expression.Clin Transl Oncol2013https://conductscience.org/library/papers/23359184PubMed
424,575,833A microRNA meta-signature for pancreatic ductal adenocarcinoma.Expert Rev Mol Diagn2014https://conductscience.org/library/papers/24575833PubMed
522,878,649MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma.Mod Pathol2012https://conductscience.org/library/papers/22878649PubMed
624,143,167MUC1 regulates expression of multiple microRNAs involved in pancreatic tumor progression, including the miR-200c/141 cluster.PLoS One2013https://conductscience.org/library/papers/24143167PubMed
730,551,350Dysregulation of key microRNAs in pancreatic cancer development.Biomed Pharmacother2019https://conductscience.org/library/papers/30551350PubMed
834,328,099Emerging roles of miRNAs in the development of pancreatic cancer.Biomed Pharmacother2021https://conductscience.org/library/papers/34328099PubMed
926,166,038miR-15b promotes epithelial-mesenchymal transition by inhibiting SMURF2 in pancreatic cancer.Int J Oncol2015https://conductscience.org/library/papers/26166038PubMed
1020,885,409Targeting microRNAs in cancer: rationale, strategies and challenges.Nat Rev Drug Discov2010https://conductscience.org/library/papers/20885409PubMed

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42,914,928Prognostic value of microRNA expression in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis.EBioMedicine2026https://conductscience.org/library/papers/42914928PubMed
42,358,587Bioinformatics-based Investigation to Unveiling The miRNA-Immunity Axis in The Tumor Microenvironment of Pancreatic Cancer.F1000Res2025https://conductscience.org/library/papers/42358587PubMed
41,331,086Deciphering KRAS inhibitor resistance.Nat Cell Biol2026https://conductscience.org/library/papers/41331086PubMed
41,329,540Serum MicroRNA-196, -200 and -423 Improve Diagnostics and Differentiate Pancreatic Ductal Adenocarcinoma From Chronic Pancreatitis.Physiol Res2025https://conductscience.org/library/papers/41329540PubMed
39,440,357Assessment of the Role of miR-30a-5p on the Proliferation and Apoptosis of Hair Follicle Stem Cells.J Cosmet Dermatol2025https://conductscience.org/library/papers/39440357PubMed

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
CTNNB11,499PubTator's text mininghttps://conductscience.org/library/genes/1499NCBI Gene
KRAS3,845PubTator's text mininghttps://conductscience.org/library/genes/3845NCBI Gene
MIR23A407,010PubTator's text mininghttps://conductscience.org/library/genes/407010NCBI Gene
MIR29C407,026PubTator's text mininghttps://conductscience.org/library/genes/407026NCBI Gene
PI35,266PubTator's text mininghttps://conductscience.org/library/genes/5266NCBI Gene
TGFB17,040PubTator's text mininghttps://conductscience.org/library/genes/7040NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39200178

GET https://conductscience.org/api/papers/v1/39200178/references?page=2